STAT

Opinion: Easing access to marijuana is not a way to solve the opioid epidemic

Expanding access to medical or recreational marijuana as an alternative to opioids for conditions like chronic pain is a bad idea, especially for America's youths.
Source: PEDRO PARDO/AFP/Getty Images

The take-home message from research published last week in JAMA Internal Medicine — let’s liberalize access to marijuana as a way to address the raging opioid epidemic — captured the public imagination. We disagree. Supporting medical or recreational marijuana as an alternative to opioids for conditions like chronic pain is a bad idea, especially for America’s youths.

Using state-level data, the authors of the JAMA study evaluated opioid-prescribing trends to Medicaid patients between 2011 and 2016 in states that started to implement medical and adult-use marijuana laws and compared them to rates in the remaining states. Opioid prescribing was about 6 percent lower in states with medical

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks